Advertisement
Table 1 Clinical characteristics of the patients with de novo Ph+ALL for in vitro and in vivo study
| Case no. | Age/sex | WBC (×10E + 9/L) | % CD34+ in blasts | % CD34+CD38− CD58− in blasts | BCR–ABL (P190/P210) | Cytogenetics | Outcome |
|---|---|---|---|---|---|---|---|
| 1 | F/23 | 26.3 | 90.5 | 5.6 | P210 | 46, XX, t(9;22) [20] | CCR |
| 2 | M/46 | 86.5 | 82.3 | 12.2 | P210 | 46, XY, t(9;22) [20] | Relapsed |
| 3 | M/40 | 65.3 | 86.5 | 8.6 | P190 | 46, XY, t(9;22) [20] | Relapsed |
| 4 | M/32 | 56.6 | 78.5 | 10.2 | P190 | 46, XY, t(9;22) [20] | CCR |
| 5 | F/50 | 167.3 | 98.6 | 11.6 | P190 | 46, XX, t(9;22) [20] | Relapsed |
| 6 | M/22 | 78.2 | 92.3 | 9.8 | P190 | 46, XY, t(9;22) [20] | Relapsed |
